COMMENT ON THE APPLE QUALCOMM SETTLEMENT Jay P. Kesan COMMENT ON THE APPLE QUALCOMM SETTLEMENT Jay P. Kesan Apple began a litigation campaign against Qualcomm in January 2017 for allegedly charging unreasonable patent royalty fees for smartphone modem chips and for abuse of its monopolistic power in the cellular industry.
Implications of Apple-Qualcomm Settlement on Wireless Communications Ecosystem Steven Bowers.Intel Corporation’s exit from the premium 5G smartphone modem chipset business creates a range of opportunities – and risks – for Chinese companies seeking to invest and capitalize on the emerging industries and use cases associated with 5G wireless technology.
The Supreme People's Court: Violations of legitimate rights and interests of foreign businessmen, especially intellectual property rights violations, shall be resolutely punished.The party group of the Supreme People's Court of China held a meeting on November 9th, 2018 to study General Secretary Xi Jinping’s speech at the opening ceremony of the first China International Import Expo and his......
Ministry of Commerce: Carrying out intellectual property protection for foreign-invested enterprises On November 9th, the State Council Information Office held a regular briefing on the State Council policy. At the meeting, Tang Wenhong, Director of the Foreign Investment Department of the Ministry of Commerce, gave a brief introduction on the improvement of the business environment in the foreign investment sector.
The Finnish company Metso sued a Chinese company for infringement, claiming 6.2 million damages in two cases. In the two cases, it is clear that the defendant, a mining machinery manufacturing company in Shenyang, Liaoning, infringed Metso’s right, but plaintiff’s loss of profits and the profits made by the defendant from the infringement were difficult to determine.The collegiate panel of this case thus considered a variety of factors, especially the advertising activities on the defendant’s WeChat public account.
Recently, the listed company Guonong Science and Technology disclosed that it would transfer a 50% stake in Shandong PKU High-tech Huatai Pharmaceutical Co., Ltd. (hereinafter referred to as Shandong Huatai) for a price of over RMB 70 million. According to media reports, Shandong Huatai has suffered losses for three consecutive years. As Shandong Huatai's operating income accounted for more than 90% of the total revenue of Guonong Science and Technology in 2017, the deal has received much attention.